HLS Therapeutics Inc.

Healthcare

TSX:HLS.TO · Toronto Stock Exchange

Market Cap $137.30M Beta 0.85 P/E (TTM) -9.6

$4.34 -2.51%

-$0.11 today

52W Low $0.00High $5.77

Vol 0.00M · Avg 0.01M

EPS (TTM) -$0.33Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-13.03%

Period High

$5.72

Period Low

$4.27

Latest

$4.34

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Auxly Cannabis Group Inc.

TSX:XLY.TO

$257.70M

Quipt Home Medical Corp.

QIPT.TO

$221.44M

Cannara Biotech Inc.

LOVE.V

$181.03M

Cardiol Therapeutics Inc.

TSX:CRDL.TO

$171.76M

BioSyent Inc.

RX.V

$160.02M

Grown Rogue International Inc.

GRIN.CN

$149.96M

Jushi Holdings Inc.

JUSH.CN

$133.80M

Helix BioPharma Corp.

TSX:HBP.TO

$108.46M

Planet 13 Holdings Inc.

PLTH.CN

$60.79M

BioNxt Solutions Inc.

BNXT.CN

$48.08M

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.